Moyamoya Syndrome Presenting as Refractory Status Epilepticus in a 32-Year-Old Female

被引:1
作者
Alhashem, Ali T. [1 ]
AlSalem, Khalid H. [2 ]
Sabihah, Sarah J. [3 ]
Alfaraj, Dunya [4 ]
机构
[1] King Faisal Univ, Emergency Med, Al Hufuf, Saudi Arabia
[2] King Hamad Univ Hosp, Emergency Med, Dammam, Saudi Arabia
[3] Najran Univ, Emergency Med, Dammam, Saudi Arabia
[4] Imam Abdulrahman Bin Faisal Univ, Emergency Med, King Fahad Univ Hosp, Dammam, Saudi Arabia
关键词
moyamoya disease; sickle cell disease: scd; tramadol; refractory status epilepticus; SICKLE-CELL-DISEASE; MANAGEMENT; CHILDREN; RISK;
D O I
10.7759/cureus.13624
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Moyamoya disease (MMD) is a rare cerebrovascular occlusion condition characterized by progressive stenosis in the terminal portion of the internal carotid arteries on both sides. The measured incidence of MMD is 0.086 per 100,000 people. MMD has variable neurological manifestations, however, seizure is a significant manifestation of MMD with few reported studies. The combination of sickle cell disease (SCD) and MMD confers a much higher risk of ischemic stroke. In this paper, we describe a 32-year-old female with a known case of SCD taking tramadol for a vaso-occlusive crisis, who was presented to the emergency department by a family member due to a low level of consciousness. Despite ongoing management, the patient developed multiple seizure attacks and intubation was performed. A computed tomography (CT) brain angiogram was performed, and the diagnosis of MMD was made. The patient was shifted to the intensive care unit (ICU) and in spite of the ongoing management in the ICU, the patient died. In this case, we highlight the importance of considering MMD as a differential diagnosis when dealing with an SCD patient who developed refractory status epilepticus.
引用
收藏
页数:4
相关论文
共 20 条
  • [1] [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P245, DOI [DOI 10.2176/nmc.52.245, 10.2176/nmc.52.245]
  • [2] Fatal overdoses of trarnadol:: is benzodiazepine a risk factor of lethality?
    Clarot, F
    Goullé, JP
    Vaz, E
    Proust, B
    [J]. FORENSIC SCIENCE INTERNATIONAL, 2003, 134 (01) : 57 - 61
  • [3] Clarot Franck, 2003, J Clin Forensic Med, V10, P125, DOI 10.1016/S1353-1131(03)00039-7
  • [4] Risk of stroke in children - Ethnic and gender disparities
    Fullerton, HJ
    Wu, YW
    Zhao, SJ
    Johnston, SC
    [J]. NEUROLOGY, 2003, 61 (02) : 189 - 194
  • [5] Revascularisation surgery for paediatric moyamoya: a review of the literature
    Fung, LWE
    Thompson, D
    Ganesan, V
    [J]. CHILDS NERVOUS SYSTEM, 2005, 21 (05) : 358 - 364
  • [6] New guideline for tramadol usage following adverse drug reactions reported to the Iranian pharmacovigilance center
    Gholami, K.
    Shalviri, G.
    Zarbakhsh, A.
    Daryabari, N.
    Yousefian, S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (02) : 229 - 237
  • [7] JOHNSON C, 2017, BLOOD S1, V130
  • [8] Seizures associated with intoxication and abuse of tramadol
    Jovanovic-Cupic, V
    Martinovic, Z
    Nesic, N
    [J]. CLINICAL TOXICOLOGY, 2006, 44 (02) : 143 - 146
  • [9] Moyamoya disease: current concepts and future perspectives
    Kuroda, Satoshi
    Houkin, Kiyohiro
    [J]. LANCET NEUROLOGY, 2008, 7 (11) : 1056 - 1066
  • [10] Menon G, 2019, ARCH MED HLTH SCI, V7, P224